Results overview: Found 20 records in 0.02 seconds.
Articles, 19 records found
Research literature, 1 records found
Articles 19 records found  1 - 10next  jump to record:
1.
14 p, 1.7 MB Mpox : Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide Study / Martín-Iguacel, Raquel (Institut Germans Trias i Pujol. Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya) ; Pericas, Carles (Institut d'Investigació Biomèdica Sant Pau) ; Bruguera Riera, Andreu (Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia, i Medicina Preventiva i Salut Pública) ; Rosell, Gemma (Subdirecció General de Vigilància i Resposta a Alertes i Emergències de Salut Pública) ; Martínez, Erica (Institut d'Investigació Biomèdica Sant Pau) ; Díaz, Yesika (CIBER Epidemiologia y Salud Pública) ; Alonso García, Lucía (Fundació Lluita Contra les Infeccions) ; Nomah, Daniel Kwakye (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Blanco, Jose Luis (Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Domingo, Pere (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Álvarez-López, Patricia (Hospital Universitari Vall d'Hebron) ; Linares, Maria Saumoy (Hospital Universitari de Bellvitge) ; Vilades Laborda, Consuelo (Instituto de Salud Carlos III) ; Mera, Arantxa (Hospital de Palamós) ; Calzado, Sonia (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Johansen, Isik Somuncu (Odense University Hospital) ; Miró, José M (Instituto de Salud Carlos III) ; Casabona-Barbarà, Jordi (Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia, i Medicina Preventiva i Salut Pública) ; Llibre, Josep M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
We investigated differences in mpox clinical outcomes in people with HIV (PWH) and without HIV (PWoH) and the impact of vaccination in Catalonia, Spain. We used surveillance data and the PISCIS HIV cohort. [...]
2023 - 10.3390/microorganisms11112701
Microorganisms, Vol. 11 (november 2023)  
2.
9 p, 544.7 KB Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI) : A Multicenter Randomized Open-Label Study (PReEC/RIS-57) / Podzamczer, Daniel (Hospital Universitari de Bellvitge) ; Micán, R. (Hospital Universitario La Paz (Madrid)) ; Tiraboschi, Juan Manuel (Hospital Universitari de Bellvitge) ; Portilla, J. (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Llibre, Josep M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ribera, E. (Hospital Universitari Vall d'Hebron) ; Vivancos, M.J. (Hospital Universitario Ramón y Cajal) ; Morano, L. (Hospital Álvaro Cunqueiro (Vigo)) ; Masiá, M. (Hospital General Universitario de Elche) ; Gómez, C. (Hospital Universitario Virgen de la Victoria-IBIMA) ; Fanjul, F. (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Payeras, A. (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ; Inciarte, Alexy (Hospital Clínic i Provincial de Barcelona) ; Estrada, V. (Hospital Clínico San Carlos-IdiSSC) ; Rivero, A. (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ; Castro, A. (Complejo Hospitalario Universitario) ; Bernal, Enrique (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ; Vinuesa, D. (Hospital Universitario San Cecilio (Granada)) ; Knobel Freud, Hernando (Hospital del Mar (Barcelona, Catalunya)) ; Troya, J. (Hospital Universitario Infanta Leonor) ; MacÍas, J. (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ; Montero, M. (Hospital Universitari i Politècnic la Fe) ; Sanz, J. (Hospital Universitario de la Princesa (Madrid)) ; Navarro-Alcaraz, Antonio (Hospital Universitari de Bellvitge) ; Caicedo, A. (Ris Red de Investigación en Sida) ; Fernández, G. (Hospital Universitari de Bellvitge) ; Martínez, Esteban (Hospital Clínic i Provincial de Barcelona) ; Moreno, S. (Hospital Universitario Ramón y Cajal) ; Universitat Autònoma de Barcelona
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) is the reference for combination therapy based on protease inhibitors due to its efficacy, tolerability, and convenience. Head-to-head randomized comparisons between D/C/F/TAF and combination therapy based on integrase inhibitors in antiretroviral-naive patients are lacking. [...]
2022 - 10.1093/ofid/ofab595
Open Forum Infectious Diseases, Vol. 9 Núm. 3 (january 2022) , p. ofab595  
3.
12 p, 658.2 KB Impact of the Introduction of a Two-Step Laboratory Diagnostic Algorithm in the Incidence and Earlier Diagnosis of Clostridioides difficile Infection / Sopena, Nieves (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Wang-Wang, Jun Hao (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Casas, Irma (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Mateu, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Castellà, Laia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; García-Quesada, María José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gutiérrez-Enríquez, Sara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Llibre, Josep M.. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pedro-Botet, M. Luisa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Fernandez Rivas, Gema (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Our aim was to determine changes in the incidence of CD infection (CDI) following the introduction of a two-step diagnostic algorithm and to analyze CDI cases diagnosed in the study period. We retrospectively studied CDI (January 2009 to July 2018) in adults diagnosed by toxin enzyme immunoassay (EIA) (2009-2012) or toxin-EIA + polymerase chain reaction (PCR) algorithm (2013 onwards). [...]
2022 - 10.3390/microorganisms10051075
Microorganisms, Vol. 10 (may 2022)  
4.
13 p, 1.8 MB Determinants of long-term survival in late HIV presenters : The prospective PISCIS cohort study / Martin-Iguacel, Raquel (Odense University Hospital (Dinamarca)) ; Reyes-Urueña, Juliana (Institut Germans Trias i Pujol. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya) ; Bruguera Riera, Andreu (Institut Germans Trias i Pujol. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya) ; Aceitón, Jordi (Institut Germans Trias i Pujol. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya) ; Díaz, Yesika (Institut Germans Trias i Pujol. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya) ; Moreno-Fornés, Sergio (Institut Germans Trias i Pujol. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Burgos, Joaquín (Hospital Universitari Vall d'Hebron) ; Tiraboschi, Juan Manuel (Hospital Universitari de Bellvitge) ; Johansen, Isik Somuncu (Odense University Hospital (Dinamarca)) ; Álvarez, Hortensia (Complejo Hospitalario Universitario de Ferrol) ; Miró, Josep M. (Instituto de Salud Carlos III) ; Casabona-Barbarà, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Llibre, Josep M.. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Late HIV diagnosis (i. e CD4≤350 cells/µL) is associated with poorer outcomes. However, determinants of long-term mortality and factors influencing immune recovery within the first years after antiretroviral treatment (ART) initiation are poorly defined. [...]
2022 - 10.1016/j.eclinm.2022.101600
EClinicalMedicine, Vol. 52 (august 2022)  
5.
14 p, 458.2 KB Cardiovascular events in delayed presentation of HIV : the prospective PISCIS cohort study / Martín-Iguacel, Raquel (Odense University Hospital (Dinamarca)) ; Vazquez-Friol, Mari Carmen (University Hospital Universitario de Ferrol) ; Burgos, Joaquín (Hospital Universitari Vall d'Hebron) ; Bruguera Riera, Andreu (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Reyes-Urueña, Juliana (Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT)) ; Moreno-Fornés, Sergio (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Aceitón, Jordi (Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT)) ; Díaz, Yesika (Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT)) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Saumoy, Maria (Hospital Universitari de Bellvitge) ; Knobel Freud, Hernando (Parc de Salut MAR de Barcelona) ; Dalmau, David (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Borjabad, Beatriz (Consorci Sanitari Integral) ; Johansen, Isik Somuncu (Odense University Hospital (Dinamarca)) ; Miro, Jose M. (Centro de Instituto de Salud Carlos III) ; Casabona-Barbarà, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Llibre, Josep M.. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
People with HIV (PWH) have a higher cardiovascular risk than the general population. It remains unclear, however, whether the risk of cardiovascular disease (CVD) is higher in late HIV presenters (LP; CD4 ≤ 350 cells/μL at HIV diagnosis) compared to PWH diagnosed early. [...]
2023 - 10.3389/fmed.2023.1182359
Frontiers in Medicine, Vol. 10 (june 2023)  
6.
12 p, 632.4 KB SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV / Nomah, Daniel Kwakye (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Llibre, Josep M (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Díaz, Yesika (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Moreno-Fornés, Sergio (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Aceitón, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bruguera Riera, Andreu (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gutiérrez-Macià, Maria (Institut d'Investigació Biomèdica Sant Pau) ; Imaz, Arkaitz (Hospital Universitari de Bellvitge) ; Suanzes, Paula (Hospital Universitari Vall d'Hebron) ; Navarro, Gemma (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Orti, Amat (Hospital de Tortosa) ; Miró, José M (Hospital Clínic i Provincial de Barcelona) ; Casabona-Barbarà, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Reyes-Urueña, Juliana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
People living with HIV (PLWH) are prioritised for SARS-CoV-2 vaccination due to their vulnerability to severe COVID-19. Therefore, the epidemiological surveillance of vaccination coverage and the timely identification of suboptimally vaccinated PLWH is vital. [...]
2022 - 10.3390/microorganisms10081666
Microorganisms, Vol. 10 (august 2022)  
7.
10 p, 1.3 MB Normalization of circulating plasma levels of miRNAs in HIV-1/HCV co-infected patients following direct-acting antiviral-induced sustained virologic response / Franco Cirera, Sandra (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Llibre, Josep M.. (Institut Germans Trias i Pujol) ; Jou, Toni (Fundació LLuita Contra les Infeccions) ; Tural, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martínez, Miguel Angel (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Universitat Autònoma de Barcelona
In a previous recent work, we recognized three plasma circulating microRNAs (miRNAs)-miR-100-5p_iso3p:-2, miR-122-5p, and miR-192-5p-that correlate largely with liver fibrosis evolution in human immunodeficiency virus type 1 (HIV-1)/hepatitis C virus (HCV) co-infected patients. [...]
2023 - 10.1016/j.heliyon.2022.e12686
Heliyon, Vol. 9 (january 2023)  
8.
7 p, 870.6 KB Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendees / Colom Cadena, Andreu (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martínez-Riveros, Héctor (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bordas, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Alonso García, Lucía (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Montoro-Fernández, Marcos (Catalunya. Generalitat) ; Romano-deGea, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Vidal-Alaball, Josep (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Solà-Segura, Elisabet (Institut Català de la Salut) ; Llibre, Josep M.. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Revollo, Boris (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Casabona-Barbarà, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Agustí, Cristina (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)
SARS-CoV-2 screening is one of the pillars of non-pharmaceutical preventive strategies to early identify and isolate infected individuals and therefore decrease community incidence. We assessed the feasibility of severe acute respiratory syndrome coronavirus 2 self-testing with antigen-detecting rapid diagnostic tests in attendees of educational settings. [...]
2023 - 10.3389/fped.2022.975454
Frontiers in Pediatrics, Vol. 10 (january 2023)  
9.
12 p, 780.3 KB Observational cohort study of rilpivirine (RPV) utilization in Europe / Cozzi-Lepri, Alessandro (Centre for Clinical Research. Epidemiology. Modelling and Evaluation (CREME). Institute for Global Health. University College London) ; Peters, Lars (CHIP. Rigshospitalet. University of Copenhagen) ; Pelchen-Matthews, Annegret (Centre for Clinical Research. Epidemiology. Modelling and Evaluation (CREME). Institute for Global Health. University College London) ; Neesgaard, Bastian (CHIP. Rigshospitalet. University of Copenhagen (Belgium)) ; De Wit, Stéphane (Université Libre de Bruxelles, Department of Infectious Diseases) ; Johansen, Isik Somuncu (Odense University Hospital (Dinamarca)) ; Edwards, Simon (Mortimer Market Centre, Department of HIV (London)) ; Stephan, Christoph (Infectious Diseases Unit. Goethe-University Hospital) ; Adamis, Georgios (General Hospital of Athens G. Gennimatas (Greece)) ; Staub, Therese (Centre Hospitalier de Luxembourg, Service des Maladies Infectieuses (Luxembourg)) ; Zagalo, Alexandra (Santa Maria University Hospital, Department of Infectious Diseases (Lisbon, Portugal)) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Elbirt, Daniel (Allergy. Immunology and HIV Unit | Kaplan. Medical Center) ; Kusejko, Katharina (University Hospital Zürich (Switzerland)) ; Brännström, Johanna (Department of Infectious Diseases. Venhälsan Södersjukhuset) ; Paduta, Dzmitry (Gomel Regional Centre for Hygiene) ; Trofimova, Tatyana (Novgorod Centre for AIDS Prevention and Control) ; Szlavik, Janos (South-Pest Hospital Centre-National Institute for Infectiology and Haematology) ; Zilmer, Kai (West-Tallinn Central Hospital, Infectious Diseases Clinic (Talinn, Estonia)) ; Losso, Marcello (Hospital J.M. Ramos Mejia (Buenos Aires)) ; Van Eygen, Veerle (Janssen Research & Development) ; Pai, Helen (Janssen Research & Development) ; Lundgren, Jens (CHIP. Rigshospitalet. University of Copenhagen) ; Mocroft, Amanda (Rigshospitalet. University of Copenhagen (Denmark)) ; Harxhi, Arjan (Medical University of Tirana (Albania)) ; Losso, M. (Hospital General de Agudos JM Ramos Mejía) ; Kundro, Mariana (Hospital General de Agudos JM Ramos Mejía) ; Schmied, B. (Institute of Science and Technology Austria (ISTA)) ; Karpov, I. (Minsk State Linguistic University) ; Vassilenko, Anna (Médecins Sans Frontières) ; Paduto, D. ; Mitsura, Victor (Gomel State Medical University) ; Clumeck, Nathan (University Hospital Brussels) ; De Wit, S. (Université Libre de Bruxelles) ; Delforge, M. (Université Libre de Bruxelles) ; Hadziosmanovic, V. (Clinical Center University of Sarajevo) ; Begovac, Josip (University of Zagreb) ; Machala, L. (Charles University in Prague) ; Jilich, David (Charles University in Prague) ; Gerstoft, J. (IT University of Copenhagen) ; Torp-Pedersen, Christian (Aalborg Universitet) ; Sedlacek, Dalibor (Fakultní nemocnice Plzeň) ; Kronborg, Gitte (University of Copenhagen) ; Benfield, Thomas (Copenhagen University Hospital Hvidovre) ; Johansen, IS (Odense University Hospital (Dinamarca)) ; Ostergaard, Leif (Aarhus University) ; Wiese, Lothar (Roskilde University) ; Friis-Moller, Nina (Zealand University Hospital) ; Nielsen, L.N. ; Zilmer, K. (Kaunas University of Technology) ; Smidt, J. (Kohtla - Jarve Jarve Gümnaasium) ; Aho, Inka (Helsinki University Central Hospital) ; Viard, Jean-Paul (Université Paris Cité) ; Girard, Pierre-Marie (University of Paris-Est) ; Pradier, Christian (Centre Hospitalier Universitaire de Nice) ; Fontas, Eric (Centre Hospitalier Universitaire de Nice) ; Duvivier, Claudine (Hôpital Universitaire Necker) ; Rockstroh, Jurgen (Universitätsklinikum Bonn) ; Degen, Olaf (University Medical Center Hamburg) ; Hoffmann, C. ; Stellbrink, H.J. (ICH Study Center) ; Stefan, C. ; Bogner, Johannes (University Hospital München) ; Fätkenheuer, Gerd (University of Cologne) ; Chkhartishvili, N. (Infectious Diseases, AIDS and Clinical Immunology Research Center) ; Sambatakou, Helen (Hippokration General Hospital (Athens)) ; Adamis, Georgios ; Paissios, N. ; Uzdaviniene, V. (Vilnius University Hospital Santariškių Klinikos) ; Staub, T. (Centre Hospitalier de Luxembourg) ; Dragas, S. ; Reiss, P. (University of Amsterdam) ; Trajanovska, J. ; Reikvam, Dag Henrik (Oslo University Hospital (Oslo, Noruega)) ; Maeland, A. (Oslo University Hospital (Oslo, Noruega)) ; Bruun, Johan (University Hospital of North Norway) ; Knysz, B. (WWF Poland) ; Szetela, Bartosz (Nicolaus Copernicus University) ; Inglot, Malgorzata (Wroclaw Medical University) ; Bakowska, E. (Hospital For Infectious Diseases (Warsaw)) ; Flisiak, Robert (Medical University of Bialystok) ; Grzeszczuk, Anna (Medical University of Bialystok) ; Parczewski, Miłosz (Pomeranian Medical University in Szczecin) ; Maciejewska, Katarzyna (Pomeranian Medical University in Szczecin) ; Aksak-Was, Bogusz (Pomeranian Medical University in Szczecin) ; Beniowski, Marek (Medical University of Silesia in Katowice) ; Mularska, Elżbieta ; Jablonowska, Elżbieta (University of Lodz) ; Kamerys, J. ; Wojcik, K. (University of Lodz) ; Mozer-Lisewska, Iwona (Uniwersytet Medyczny im.Karola Marcinkowskiego w Poznaniu) ; Rozplochowski, Błażej (Poznan University of Medical Sciences) ; Zagalo, A. ; Radoi, Roxana (Clinical Hospital Of Infectious Diseases "Dr. Victor Babes") ; Oprea, Cris (Joint Institute for Nuclear Research) ; Yakovlev, A. (Saint Petersburg State University) ; Trofimora, T. ; Khromova, I. (Tomsk Regional Center of AIDS and infectious diseases prophylaxis and control" (RCAIDPC)) ; Kuzovatova, Elena (Blokhina Scientific Research Institute of Epidemiology and Microbiology of Nizhny Novgorod) ; Borodulina, Elena ; Vdoushkina, Elena (Samara State Medical University) ; Ranin, Jovan (Klinički centar Srbije) ; Tomazic, J. (Ljubljana University Medical Centre) ; Miro, Josep M. (Instituto de Salud Carlos III) ; Laguno, Montse (Hospital Clínic i Provincial de Barcelona) ; Martinez, E. ; Garcia, F. ; Blanco, J.L. (Hospital Clínic i Provincial de Barcelona) ; Martinez-Rebollar, María (Hospital Clínic i Provincial de Barcelona) ; Mallolas, J. ; Callau, Pilar (Universitat de Barcelona) ; Rojas, J. (Hospital Clínic i Provincial de Barcelona) ; Moreno, Santiago (Pontifical Catholic University of Argentina) ; del Campo, Santos (Hospital Universitario Ramón y Cajal (Madrid)) ; Jou, A. (IrsiCaixa Institute for AIDS Research) ; Paredes, Roger (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Puig, Jordi (Universitat Autònoma de Barcelona) ; Llibre, Josep M.. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Santos, J.R. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Domingo, Pere (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Gutierrez, M. ; Mateo, G.M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Sambeat, A. ; Laporte, J.M. ; Svedhem, V. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Thalme, Anders (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Sonnerborg, A. ; Flamholc, L. (Skåne University Hospital (Suècia)) ; Kusejko, Katharina (University of Zurich) ; Weber, R. (Universitäts-Herzzentrum Freiburg - Bad Krozingen) ; Calmy, Alexandra (University of Geneva) ; Furrer, Hansjakob (Inselspital, Universitätsspital Bern) ; Battegay, Manuel (University of Basel) ; Schmid, P. (Cantonal Hospital of Schwyz) ; Kuznetsova, A. (Kyiv National Economic University) ; Mikhalik, Julia ; Sluzhynska, M. (International HIV/AIDS Alliance in Ukraine) ; Milinkovic, Ana (Imperial College London) ; Johnson, A.M. ; Simons, E. ; Edwards, S. (Brookhaven National Laboratory) ; Phillips, A.M. ; Johnson, A. (University of Colorado Boulder) ; Mocroft, A. ; Orkin, Chloe (Queen Mary, University of London) ; Winston, Alan (Imperial College London) ; Clarke, A. (University of Sussex) ; Leen, Clifford (The University of Edinburgh)
Introduction: Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce. Methods: Participants of EuroSIDA were included if they had started a RPV- or an EFV-containing regimen over November 2011-December 2017. [...]
2022 - 10.1186/s12981-022-00457-0
AIDS Research and Therapy, Vol. 19 Núm. 1 (december 2022) , p. 38  
10.
19 p, 436.8 KB Determinants of Depressive Symptoms in People Living with HIV : Findings from a Population-Based Study with a Gender Perspective / Bayes-Marin, Ivet (Universitat Internacional de Catalunya) ; Egea Cortés, Laia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Palacio-Vieira, Jorge (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bruguera Riera, Andreu (Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva) ; Mesías-Gazmuri, Jocelyn (Universitat Autònoma de Barcelona. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva) ; Llibre, Josep M.. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Fernández, Emma (Hospital Clínic i Provincial de Barcelona) ; Imaz, Arkaitz (Institut d'Investigació Biomèdica de Bellvitge) ; Forero, Carlos G. (Universitat Internacional de Catalunya) ; Agustí, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Arbones-Fernández, Laia (Hospital de Mataró. Consorci Sanitari del Maresme) ; Miró, José M. (Universitat de Barcelona) ; Casabona-Barbarà, Jordi (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Reyes-Ureña, Juliana (Generalitat de Catalunya)
Depressive symptoms are common among people living with HIV (PLWH). The aim of this study was to identify the determinants of depressive symptoms in PLWH in Spain. A total of 1060 PLWH participated in this cross-sectional study and completed the Patient Health Questionnaire-9. [...]
2023 - 10.3390/ijerph20043687
International journal of environmental research and public health, Vol. 20 (february 2023)  

Articles : 19 records found   1 - 10next  jump to record:
Research literature 1 records found  
1.
173 p, 2.2 MB Clinical impact of HIV-1 resistance against nonnucleoside analogue reverse transcriptase Inhibitors / Llibre Codina, Josep Maria ; Paredes, Roger, dir. ; Clotet Sala, Bonaventura, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
Els inhibidors de la transcriptassa inversa no anàlegs de nucleòsids (ITINAN) s'utilitzen sovint en el tractament antiretroviral (TAR) per la seva eficàcia i simplicitat. La resistència està causada per mutacions específiques a posicions de resistència. [...]
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are popular components of antiretroviral therapy due to their efficacy and simplicity. Resistance is caused only by specific mutations at drug-resistance positions. [...]

Bellaterra : Universitat Autònoma de Barcelona, 2015  

See also: similar author names
1 Llibre, J.M.
797 Llibre, Jaume
797 Llibre, Jaume
10 Llibre, Jaume,
2 Llibre, Jaume, 0000-0002-9511-5999
2 Llibre, Jaume, 0000-0002-9511-5999
1 Llibre, Josep M
12 Llibre, Josep M..
1 Llibre, Josep Ma
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.